共 50 条
- [31] Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial[J]. AMERICAN JOURNAL OF NEPHROLOGY, 2019, 50 (05) : 345 - 356Ruilope, Luis M.Agarwal, RajivAnker, Stefan D.Bakris, George L.Filippatos, GerasimosNowack, ChristinaKolkhof, PeterJoseph, AmerMentenich, NicolePitt, BertramAizenberg, DiegoBartolacci, InesBesada, DiegoBittar, JulioChahin, MarianoElbert, AliciaGelersztein, ElizabethLiberman, AlbertoMaffei, LauraPerez Manghi, FedericoSanabria, HugoVallejos, AugustoVines, GloriaWassermann, AlfredoAbhayaratna, WalterColman, PeterColquhon, DavidEkinci, ElifMacIsaac, RichardMah, Peak MannNelson, CraigPackham, DavidPape, AlexiaRoger, SimonStephenson, HugoSuranyi, MichaelTopliss, DuncanVandeleur, JamesWittert, GaryWynne, Katie-JaneClodi, MartinDrexel, HeinzEbenbichler, ChristophFliesser-Goerzer, EvelynHanusch, UrsulaLudvik, BernhardNeudorfer, PeterPaulweber, BernhardPrager, RudolfPreiss, Wolfgang
- [32] Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide[J]. DIABETES OBESITY & METABOLISM, 2018, 20 (01): : 42 - 49Gerstein, Hertzel C.Colhoun, Helen M.Dagenais, Gilles R.Diaz, RafaelLakshmanan, MarkPais, PremProbstfield, JeffreyRiddle, Matthew C.Ryden, LarsXavier, DenisAtisso, Charles M.Avezum, AlvaroBasile, JanChung, NamsikConget, IgnacioCushman, William C.Franek, EdwardHancu, NicolaeHanefeld, MarkolfHolt, ShaunJansky, PetrKeltai, MatyasLanas, FernandoLeiter, Lawrence A.Lopez-Jaramillo, PatricioCardona-Munoz, Ernesto G.Pirags, ValdisPogosova, NanaRaubenheimer, Peter J.Shaw, JonathanSheu, Wayne H-H.Temelkova-Kurktschiev, Theodora
- [33] Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics[J]. OPHTHALMIC EPIDEMIOLOGY, 2016, 23 (06) : 347 - 353Ervin, Ann-MargretMkocha, HarranMunoz, BeatrizDreger, KurtDize, LauraGaydos, CharlotteQuinn, Thomas C.West, Sheila K.
- [34] EFFECTS OF CANAGLIFLOZIN ON CARDIOVASCULAR, RENAL AND SAFETY OUTCOMES BY BASELINE LOOP DIURETIC USE: DATA FROM THE CREDENCE TRIAL[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1852 - 1852Neuen, BrendonMahaffey, KennethCannon, Christopher P.Jardine, MegHeerspink, Hiddo L.Neal, BruceArnott, ClareZhou, ZienCharytan, David M.Agarwal, RajivBakris, George L.De Zeeuw, DickGreene, TomLevin, AdeeraWheeler, David C.Rosenthal, NormanZhang, HongZinman, BernardPerkovic, VladoPollock, Carol
- [35] A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: Rationale, design, and baseline patient characteristics[J]. AMERICAN HEART JOURNAL, 2008, 156 (04) : 641 - 648Abraham, William T.Burkhoff, DanielNademance, KoonlaweeCarson, PeterBourge, RobertEllenbogen, Kenneth A.Parides, MichaelKadish, Alan
- [36] Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)[J]. DIABETES & VASCULAR DISEASE RESEARCH, 2015, 12 (03): : 164 - 174Marx, NikolausRosenstock, JulioKahn, Steven E.Zinman, BernardKastelein, John J.Lachin, John M.Espeland, Mark A.Bluhmki, ErichMattheus, MichaelaRyckaert, BartPatel, SanjayJohansen, Odd ErikWoerle, Hans-Juergen
- [37] Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial[J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (07) : 2872 - 2879Chertow, Glenn M.Correa-Rotter, RicardoBlock, Geoffrey A.Drueke, Tilman B.Floege, JuergenGoodman, William G.Herzog, Charles A.Kubo, YumiLondon, Gerard M.Mahaffey, Kenneth W.Mix, Thomas-ChristianMoe, Sharon M.Wheeler, David C.Parfrey, Patrick S.
- [38] Efficacy and safety outcomes of dulaglutide by baseline HbA1c: A post hoc analysis of the REWIND trial[J]. DIABETES OBESITY & METABOLISM, 2022, 24 (09): : 1753 - 1761Franek, EdwardGerstein, Hertzel C.Riddle, Matthew C.Nicolay, ClaudiaHickey, AnaBotros, Fady T.Loo, Li Shen
- [39] Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)[J]. DIABETES OBESITY & METABOLISM, 2015, 17 (04): : 395 - 402Bethel, M. A.Green, J. B.Milton, J.Tajar, A.Engel, S. S.Califf, R. M.Holman, R. R.
- [40] Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial[J]. DIABETES OBESITY & METABOLISM, 2023, 25 (07): : 1932 - 1941McGuire, Darren K.Busui, Rodica P.Deanfield, JohnInzucchi, Silvio E.Mann, Johannes F. E.Marx, NikolausMulvagh, Sharon L.Poulter, NeilEngelmann, Mads D. M.Hovingh, G. KeesRipa, Maria SejerstenGislum, MetteBrown-Frandsen, KirstineBuse, John B.